Sickle Cell Disease
📧 Sign up to get email alerts when something new happens for Sickle Cell Disease.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2024-09-26EMA recommends suspension of sickle cell disease medicine Oxbryta
EMA recommends suspending the sickle cell disease medicine Oxbryta (voxelotor) as a precaution while emerging data are reviewed.
-
EMA safety_alert · 2021-07-23CHMP endorses review finding no link between viral vector in Zynteglo and blood cancer
The CHMP endorses a review finding that there is no link between the viral vector used in Zynteglo and the development of blood cancer.
-
EMA safety_alert · 2021-07-09EMA finds no evidence linking viral vector in Zynteglo to blood cancer
The EMA reports no evidence that the viral vector used in Zynteglo is linked to blood cancer, though continued monitoring is advised.